WebsiteGear Logo Log In
New User? Sign Up
About | Contact | FAQ
  Home News Technology Software Products Monday, January 17, 2022 
Add Press Release News | News Feeds Feeds | Email This News Email


FDA Authorizes PrecisionOS to Market VR Surgical Planning Tool
Wednesday, December 8, 2021

Software Provides 3D Reconstruction of Patient CT Scans Via Oculus Quest 2

VANCOUVER, BC, Nov. 30, 2021 /PRNewswire/ - PrecisionOS(®) has received a 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market InVisionOS(TM) a patient specific planning tool using Virtual Reality (VR). The patented software, to be available in early 2022, lets surgeons use an Oculus Quest 2 device to do preoperative planning.

InVisionOS is a next generation patient specific planning tool. Currently surgeons view a simulated 3D image of the patient on a computer screen and then carry that mental model to the operating room. InVisionOS software automatically converts the patient's computed tomography (CT) scan from any PACS system into a 3D reconstruction within seconds. Surgeons can then use the Oculus Quest 2 to view, manipulate and isolate relevant anatomical areas prior to performing the actual surgical procedure.

"We focus on developing products that improve the confidence, competency and proficiency of surgeons, ultimately benefiting patient outcomes," says Danny Goel, M.D., CEO, PrecisionOS. "Our new InVisionOS software, which took four years to develop, allows surgeons to visualize patient specific needs and better plan for surgery."

InVisionOS is a class-II medical device cleared under the FDA's 510(k) premarket submission program, which required that the company demonstrate the safety and effectiveness of the device.

About PrecisionOS
PrecisionOS was founded in partnership with clinical orthopedic surgeon educators and an expert group of XR (virtual reality, augmented reality and mixed reality) developers to create simulation training for practicing surgeons, residents and surgical device representatives. Participants using PrecisionOS modules engage in a realistic operating environment, alone or in collaboration with other trainees anywhere in the world, test their knowledge and desire to try alternate approaches, receive instructive feedback and repeat procedures until achieving proficiency. With InVisionOS, a patient specific planning tool, the company is expanding into the provision of next generation products for preoperative surgery and simulation training and education.

PrecisionOS is based in Vancouver, BC, with collaborative affiliations with more than 40 major medical institutions in the U.S. and Canada. The company's software is being used in more than 40 countries and 600 cities globally. For more information please visit www.precisionostech.com.

Media Contact:
Elaine Murphy; 818.613.1951; emurphypr@outlook.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/fda-authorizes-precisionos-to-market-vr-surgical-planning-tool-301433571.html

SOURCE PrecisionOS Technology



Email This News Email | Submit To Slashdot Slashdot | Submit To Digg.com Digg | Submit To del.icio.us Del.icio.us | News Feeds Feeds

RELATED NEWS ARTICLES
Nav ICP DAS Partners with IoT Software Provider Exosite to Introduce "ExoWISE" Solution | Jan 17, 2022
Nav Tidel Announces the TR180 Cash Recycler | Jan 17, 2022
Nav Worldwide Next-Generation Network Industry to 2026 - Huge Investments by the Government and Companies Presents Opportunities | Jan 14, 2022
Nav Tuya Smart at CES 2022: IoT Security Products in Spotlight as COVID-19 Spurs Global Demand for IoT | Jan 14, 2022
Nav Location-Based Services Market to Record USD 152.95 Mn Growth | Alibaba Group Holding Ltd., Alphabet Inc., and Apple Inc. emerge as dominant players | Technavio | Jan 14, 2022
Nav Global Big Data in Telecom Analytics Market Report 2021-2026: Business Drivers, Application Use Cases, Vendor Landscape, Value Chain Analysis, Case Studies | Jan 14, 2022
Nav Virtual Reality (VR) Market Size is Projected To Reach USD 26860 Million By 2027 At A CAGR of 19.0% - Valuates Reports | Jan 14, 2022
Nav Scientific Systems Company, Inc. (SSCI) Awarded Army Contract to Prototype Capability to Autonomously Compose and Orchestrate Satellite and UAV teams for Tactical ISR | Jan 14, 2022
Nav Computer Vision Market to Reach $41.11 Bn, Globally, by 2030 at 16.0% CAGR: Allied Market Research | Jan 14, 2022
Nav BMC Innovations Provide Greater Data Visibility and Accelerate Mainframe DevOps Adoption | Jan 14, 2022
NEWS SEARCH

FEATURED NEWS | POPULAR NEWS
Submit News | View More News View More News